Recent Clinical Trials

Mexico

Alecardio
Spire I & II

Alecardio

Effect Of Aleglitazar On Cardiovascular Outcomes After Acute Coronary Syndrome With Type 2 Diabetes Mellitus.

Study Metrics

Sites Initiated

37

Sites Randomized

35

Patients Screened

415

Patients Randomized

369

Trials in Other Countries

Argentina - Brazil - Colombia

Argentina

Trials

Brazil

Trials

Colombia

Trials

Interested in Latin America?

Request a free consultation with our regional experts